Neurological complications in HIV

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 11, Issue 6, 2011, Pages 571-575

  Hogan, Celia ^a   Wilkins, Ed ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CLINDAMYCIN; COCAINE; COTRIMOXAZOLE; DIDANOSINE; FLUCONAZOLE; FLUCYTOSINE; FOLINIC ACID; PYRIMETHAMINE; STAVUDINE; STEROID; SULFADIAZINE; ZALCITABINE;

ASEPTIC MENINGITIS; BELL PALSY; BRACHIAL NEURITIS; BRAIN BIOPSY; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFERENCE PAPER; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISTAL SENSORY PERIPHERAL NEUROPATHY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FACIAL NERVE PARALYSIS; GUILLAIN BARRE SYNDROME; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MYELITIS; NEURITIS; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SENSORY NEUROPATHY; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 83755183840     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.11-6-571     Document Type: Conference Paper

References (12)

1. Shapshak P, Kangueane P, Fijimura RK et al. Editorial NeuroAIDS review. AIDS 2011;25:123-41.
2. Letendre SL, Ellis RJ, Everall I et al. Neurologic complications of HIV disease and their treatment. Top HIV Med 2009;17:46-56.
3. Childs EA, Lyles RH, Selnes OA et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607.
4. Parsons TD, Tucker KA, Hall CD et al. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS 2006;20:1591-5. (Pubitemid 44162400)
5. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002;8(Suppl 2):115-21. (Pubitemid 36097787)
6. Letendre S,Marquie-Beck J, Capparelli E et al.; CHARTER group. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration of the central nervous system. Arch Neuro 2008;65:65-70.
7. Kaplan JE, Benson C Holmes KK et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58:1-207.
8. Portegies P, Solod L, Cinque P et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Euro J Neurol 2004;11:297-304. (Pubitemid 38903562)
9. Mirrales P, Berenguer J, Garcia de viedma D et al. treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998;12:2467-72.
10. Clifford DB, Yiannoutsos C, Glicksman M et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999;52:623-5. (Pubitemid 29075615)
11. Arribas JR, Clifford DB, Fichtenbaum CJ et al. Detection of Ebstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 1998;33:1580-3.
12. Dobbs MR, Berber JR. Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 2009;7:1263-71.